2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide and close analogues inhibit glucose stimulated insulin release through activation of Kir6.2/SUR1 K-ATP channels of beta cells. (C) 2004 Elsevier Ltd. All rights reserved.
2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide and close analogues inhibit glucose stimulated insulin release through activation of Kir6.2/SUR1 K-ATP channels of beta cells. (C) 2004 Elsevier Ltd. All rights reserved.